Abstract
Pharmacogenomics is changing the way drugs are being developed, approved and used. The Gurwitz et al article found in the previous issue is a timely 'call to arms' to ensure that this important field does not remain the wisdom of few, but becomes widely accepted and used. We are at a critical stage in pharmacogenomics: the science is not new, but has experienced a significant boost since the human genome project has been completed. Now is the time to capitalize on what basic science has provided and translate it into clinical practice. However, this can only happen if physicians and other health-care professionals, as well as patients, are being educated and become knowledgeable about pharmacogenomics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.